Effects of Abciximab, Ticlopidine, and Combined Abciximab/Ticlopidine Therapy on Platelet and Leukocyte Function in Patients Undergoing Coronary Angioplasty
- 14 March 2000
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 101 (10) , 1122-1129
- https://doi.org/10.1161/01.cir.101.10.1122
Abstract
Background—Abciximab and ticlopidine reduce adverse cardiovascular events after percutaneous transluminal coronary angioplasty (PTCA). The goal of the current study was to determine if combined abc...Keywords
This publication has 33 references indexed in Scilit:
- Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.Journal of Clinical Investigation, 1997
- Effects of Integrelin on Platelet Function in Flow Models of Arterial ThrombosisJournal of Cardiovascular Pharmacology, 1997
- Leukocyte activation with platelet adhesion after coronary angioplasty: A mechanism for recurrent disease?Journal of the American College of Cardiology, 1996
- A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery StentsNew England Journal of Medicine, 1996
- Neutrophil activation after percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1994
- Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profileJournal of the American College of Cardiology, 1992
- Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.Journal of Clinical Investigation, 1986
- Visualization and analysis of mural thrombogenesis on collagen, polyurethane and nylonBiomaterials, 1986
- The role of platelet membrane glycoproteins Ib and IIb‐IIIa in platelet adherence to human artery subendotheliumBritish Journal of Haematology, 1986
- A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.Journal of Clinical Investigation, 1983